- Esserman, Laura;
- Yau, C;
- Sninsky, J;
- Kwok, S;
- Wang, A;
- Degnim, A;
- Ingle, JN;
- Gillett, C;
- Tutt, A;
- Waldman, F;
- Moore, D
Introduction: Outcome predictors in use today are prognostic only for hormone receptor-positive (HRpos) breast cancer. Although microarray-derived multigene predictors of hormone receptor-negative (HRneg) and/or triple negative (Tneg) breast cancer recurre